Kaitlin Domangue, Author at Green Market Report - Page 2 of 13

Kaitlin DomangueKaitlin DomangueNovember 17, 2020


It’s time for your Daily Hit of cannabis financial news for November 17th, 2020. 

On the Site 

Trulieve Continues to Flex With Strong Revenue Florida-based Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) reported revenue of $136.3 million for the third-quarter ending September 30, 2020. This was a 13% sequential increase over the second quarter and topped the Yahoo Finance analyst estimate for revenue of $131 million. Trulieve also delivered a positive net income of $17.4 million, or $0.15 per diluted share, easily beating the Yahoo Finance analyst estimate of $0.22.

Greenlane Beats On Revenue, Misses On EPS

The smoking accessory e-commerce giant Greenlane Holdings, Inc. (Nasdaq: GNLN) reported that its net sales fell 20% to $35.8 million in the third quarter ending September 30, 2020 versus $44.9 million in the 2019 third quarter. This narrowly topped the Yahoo Finance analyst estimates for revenue of $35.7 million. The company also delivered a loss per share of ($0.35) which missed the analyst estimates for a loss per share of ($0.10).

Dutchie Plus Aims to be Shopify for Cannabis 

Cannabis e-commerce company Dutchie,  has launched  “Dutchie Plus,” a fully customizable online shopping experience. Dutchie Plus will allow dispensaries to create seamless online shopping experiences through open APIs and powerful back-end tools, including access to deep analytical data to drive sales and a messaging platform to connect directly with customers.

In Other News

Curaleaf Announces New CEO Effective January 1st, 2021 + Record Third Quarter Results 

Current Curaleaf President, Joseph Bayern, has been appointed as the company’s next CEO. This change will become effective on January 1st, 2021. 

The company released their third quarter earnings today and reported a record revenue of $215.3 million. In addition, they reported a record adjusted EBITDA of $42.3 million, which grew more than 4x 2019 levels. This is a sequential growth of 51%. The company also recorded a gross profit margin of 50% on cannabis sales.

Juva to Begin Trading on CSE

California-based cannabis life sciences company, Juva, announced today they will begin trading on the Canadian Securities Exchange. The company will trade under the ticker symbol, JUVA.


Kaitlin DomangueKaitlin DomangueNovember 13, 2020


Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) reported their third quarter results for 2020 last night. Overall, the cannabis company reported a very strong quarter. 

Combined revenue for Q3 totaled $54,162. This is a whopping 64% quarter over quarter increase, with Q2’s revenue reaching $33,012. Q3’s results are an even bigger jump from the same time last year, increasing by 145%. 

Columbia Care truly shined in other areas as well, the company’s combined adjusted gross profit increased 300% year over year, Q3’s total capping off $21,157 – coming from just $5,290 in Q3 2019. The company reported Q2 2020’s combined adjusted gross profit to be $11,908, so the quarter over quarter jump was still pretty significant at 78%. 

In addition to increasing both profit and revenue, the cannabis company also increased their gross margin. While not a huge Q2 to Q3 jump, 36% and 39% respectively, the increase was still there. Columbia Care definitely increased their gross margin year over year, reporting a gross margin of 24% in Q3 2019. 

Additionally, combined adjusted EBITDA was reported at $4,226 for Q3 of 2020, with Q2 2020 reporting $4,734. 

State Updates

In addition to overall updates and earning reports from Columbia Care, they went into depth about each of the states they operate in – and what exactly is on the horizon. 

They gave so many updates, this is by no means exhaustive information. But, some key highlights are: prepping for Arizona’s transition into an adult-use market in 2021, signed a definitive agreement in Q3 to acquire LA-based Project Cannabis, opened a new dispensary in Illinois, with revenue up in essentially every state they’re in. Ultimately, the company is making moves everywhere they are – and those plans are set to continue in motion during 2021. 

“As we look ahead, we will continue to focus on driving growth and profitability in our core markets while capitalizing on opportunistic M&A,” said Nicholas Vita, CEO of Columbia Care. “We will also continue executing on our organic growth strategy, as reflected by our expansion programs in AZ, IL, MA, MO, NJ, NY, UT, and VA along with our recent medical cultivation license award in West Virginia. Our balance sheet remains strong and our recent debt financing continues to reflect the confidence the institutional community has in the operational foundation we have built. We look forward to maintaining significant momentum through the fourth quarter and into 2021 as even more of our markets convert to adult-use sales.”

“Our growth strategy and operational discipline resulted in Columbia Care generating another quarter of record results,” Vita continued. “While we are delighted to announce significant year-over-year and sequential growth in revenue, gross margin and EBITDA, transitioning to an EBITDA positive business is the milestone we have been eager to surpass. We completed our acquisition of The Green Solution (TGS) in the third quarter, solidifying our leadership position in the world’s second largest cannabis market. TGS adds profitable scale to our national portfolio of brands and brings considerable expertise to ensure our transition to adult use market frameworks is successful in every respect. It opens the door for Columbia Care to further press our leadership position and leverage our know-how and experience across markets nationally. I am extremely proud of the team’s unwavering focus on day to day execution in each market, as well as our continued national focus on quality, innovation, customer care and community service. As we integrate and leverage our pipeline of acquisitions, I expect the power and uniqueness of our operating platform to further distinguish Columbia Care in each of our core functional areas. With strong momentum and political tailwinds, we are reiterating our previously stated revenue, gross margin, and adjusted EBITDA guidance for the full year 2020.”

Kaitlin DomangueKaitlin DomangueNovember 12, 2020


It’s time for your Daily Hit of cannabis financial news for November 12th, 2020. 

On the Site

Charlotte’s Web Revenue Declines But On Target For Estimates

Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX:CWBHF) reported financial results for the third quarter ended September 30, 2020, with revenue rising to $25.2 million versus $25.1 million in 2019 and on target for the Yahoo Finance average estimate. The net loss was $6.6 million which was high than last year’s net loss of $1.3 million.

Verano Buys AltMed To Create Largest Private Cannabis Company

Verano Holdings, LLC is buying and merging with Alternative Medical Enterprises, LLC, Plants of Ruskin, LLC,  called AltMed to create the largest privately-owned cannabis company. The value of the transaction was not disclosed.

Compass Pathways Has Enough Cash To Last To 2023

Psychedelic company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the third quarter of 2020 and gave an update on recent progress across its business. The company reported a net loss of $16.6 million and essentially no income as the company is focused on research at this time. The company has cash of $196.5 million as of 30 September 2020, which is expected to fund operations into 2023.

Akerna Pins Hopes On New Markets

Cannabis technology company Akerna (Nasdaq: KERN) announced financial results for its quarter ending September 30, 2020 with revenue rising 16% to $3.7 million over last year’s $3.1 million for the same time period. Akerna missed the Yahoo Finance average analyst estimate for revenue of $4.49 million. They hope to enrich their efforts by expanding their market. 

Acreage Holdings Revenue Up 42%

Cannabis giant, Acreage Holdings, (CSE: ACRG.A.U, ACRG.B.U), (OTC: ACRHF, ACRDF) reported their third-quarter earnings for 2020 after the market closed last night. The company’s reported revenue was $31.7 million, a 42% increase compared to the same period in 2019. It also was a 17% increase compared to the second quarter this year.

In Other News

Aurora Cannabis Raising $150 Million 

Aurora Cannabis announced they are selling 20 million units for $7.50 a piece in order to raise gross proceeds that equal $150 million. According to Aurora Cannabis, their portion of the proceeds will be used to “fund growth opportunities, working capital, and other general corporate purposes.” Underwriters will purchase the entirety of the issue with a 30-day option to buy an additional 15% of units offered, with the same terms and conditions applying. The units are a comprised of a single share of Aurora’s common stock and a half of a warrant.

This issue adds 20 million new shares to the company’s count, totaling just over 160 million shares outstanding. Aurora was down 8% in mid-afternoon trading today because of this stockholder dilution. 


Kaitlin DomangueKaitlin DomangueNovember 12, 2020


Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF) has reported its earnings for the third quarter of 2020. Overall, the company’s balance sheet was strong and retained a positive cash flow for the third consecutive quarter. 

Green Thumb’s revenue increased 31.3% quarter-over-quarter, and year-over-year 131.% to $157.1 million. The company’s gross margin for the third quarter of 2020 was 55.4%, an increase from a 53.2% gross margin the quarter prior.

The company’s adjusted operating EBITDA increased by 50% to $53.2 million, or 33.9% of revenue for the third quarter of 2020. The prior quarter ended with an adjusted EBITDA of $35.4 million, or 29.6% of revenue. 

As of September 30th, 2020, Green Thumb’s current assets totaled $159.1 million and included cash and cash equivalents equaling $78.1 million. The company reported a total debt outstanding of $97.1 million, $0.3 million being due within 12 months. 

Green Thumb Industries reported a net income attributable to the company of $9.6 million, or $0.4 per basic diluted share, calling this feat a “new milestone.” 

“This was an excellent quarter for Green Thumb as we delivered substantial revenue growth and our ‘Enter, Open, Scale’ strategy is generating meaningful operating leverage across our business,” said Ben Kovler, Chairman, Founder, and CEO of Green Thumb Industries. We expanded gross margins and EBITDA margins quarter-over-quarter while delivering positive net income for the first time. This was driven by the execution of our capital projects in Illinois, New Jersey, Pennsylvania and Ohio, and the rebound in our Nevada and Massachusetts markets following the initial impact of COVID-19. We are poised to further benefit from the strong tailwinds driving a robust, multi-billion-dollar marketplace.” 

Kovler continued, “Momentum remains strong across the country and in our business. The national election saw a green wave sweep across the country with five states – New Jersey, Montana, South Dakota, Arizona and Mississippi – all legalizing their respective cannabis programs. New Jersey is great news for us as we think that legal market has the potential to mirror Illinois – a single state, multi-billion dollar legal cannabis market about to be born. There was resounding support for our mission to promote well-being through cannabis and we remain bullish on our strategic position and the long-term prospects of our business.”

Consumer Packaged Goods Data 

As of September 30th, 2020, the company’s family of consumer brands are available in retail locations in eleven states: Colorado, California, Connecticut, Illinois, Florida, Maryland, Massachusetts, Nevada, New Jersey, Ohio and Pennsylvania. 

The company’s gross branded-product sales grew sequentially by approximately 32.6% quarter-over-quarter, primarily driven by a production distribution expansion. The company continues to diversify its brand portfolio with the launch of Snoozzzeberry, a gummies line under the incredibles brand in Illinois and Nevada. 

Retail Data

Retail revenue increased by 27.9% quarter-over-quarter, primarily being driven by increased foot traffic in established stores. Comparable sales growth exceeded 65%, on a base of 25 stores. 

Green Thumb Industries also partnered with the Last Prisoner Project in an attempt to help raise awareness and funds towards the incredibly important cause. The company also announced the launch of the License Education Assistance Program, designed to equip social equity business applicants for success in Illinois.

Kaitlin DomangueKaitlin DomangueNovember 12, 2020


Cannabis giant, Acreage Holdings, (CSE: ACRG.A.U, ACRG.B.U), (OTC: ACRHF, ACRDF) reported their third-quarter earnings for 2020 after the market closed last night. The company maintains a diverse cannabis portfolio, with cultivation, manufacturing, and retail operations in the United States, though they are domiciled in British Columbia, Canada. 

The company’s reported revenue was $31.7 million, a 42% increase compared to the same period in 2019. It also was a 17% increase compared to the second quarter this year. Partner revenue was $17 million, which is a drastic increase of 79% compared to the second quarter of 2020. Acreage Holdings reported a net loss attributed to Acreage was $35.7 million, while adjusted net loss attributable to Acreage was $14.3 million. 

The company’s gross margin was 42.5%, which represents an 80 basis point decrease compared to the same period in 2019 and a 110 basis point increase from the second quarter of 2020. Acreage Holdings attributes this year over year gross margin decline to a significant wholesale opportunity in Massachusetts, which didn’t repeat this year. 

The company’s company-owned, same store sales growth was 36%, effectively making this the seventh-consecutive quarter of double-digit same store sales comparisons. Same store sales growth was 22% for the entities managed by Acreage. 

Adjusted EBITDA was a loss of $6.9 million, compared to an $11.7 million loss over the same period in 2019. Managed entities reported a loss of $4.7 million compared to a $0.6 million loss in 2019. 

Bill Van Faasen, the Interim Chief Executive Officer of Acreage Holdings, said “Our core profitability is in sight in the first half of 2021. Much work remains, but we are absolutely on the right path both short and long-term, with a team that’s as energized and results-focused as it’s ever been.” 

“I am pleased with another solid quarter of improving fundamentals. Our refocused strategy continues to work. Operational excellence led to improved financials and a stronger balance sheet,” said Van Faasen. 

Acreage Holdings is, hopefully, on an upwards trend after the full wrath of 2020 was unleashed on us all. The company was among those companies who furloughed employees during the coronavirus pandemic, temporarily terminating 122 employees from field operations teams and the corporate office. They also temporarily stopped all business activities including wholesale and dispensaries in Maryland and North Dakota. 

In other exciting news for Acreage, the company has started adult-use sales in Massachusetts with their dispensary The Botanist to be located in Shrewsbury, Massachusetts. The Botanist began sales on November 10th. 

Kaitlin DomangueKaitlin DomangueNovember 11, 2020


It’s time for your Daily Hit of cannabis financial news for November 11th, 2020. 

On the Site 

Harvest Health Touts Arizona Potential During Earnings Call

Harvest Health & Recreation Inc. (OTCQX: HRVSF) reported its financial results for the third quarter of 2020 after the market closed on Tuesday with revenue rising 86% to $61.6 million. This was a sequential increase of 11% compared to $55.7 million in the second quarter of 2020. Harvest Health expects to be a huge part of Arizona’s adult-use cannabis market, which was just voted into effect in the 2020 elections. 

Aleafia Revenue Is Flat, Says Sales Set To Improve

Aleafia Health Inc. (OTC: ALEAF) reported its financial results for the quarter ending September 30, 2020, with net revenue of $4.9 million and revenues were flat from the quarter ending in 2019.

“We expect to have our strongest quarter to date in Q4 2020 as we progress towards significant sequential growth in medical, adult-use, wholesale and international cannabis sales. The strategic path we’ve executed upon, from building out facilities, to receiving three major licenses in 2020, to formulating new products, is now bearing fruit. With the introduction of vape cartridges, sublingual strips, and with many more launches to come, the commercialization of our business at scale is truly in full swing,” said Aleafia Health CEO Geoffrey Benic

Survey shows 75% of veterans are interested in cannabis

According to a 2019 survey conducted by Iraq and Afghanistan Veterans of America (IAVA), 75% of military veterans say they’d consider using either “cannabis or cannabinoid products as a treatment option.” 83% of respondents expressed their support for medical cannabis access, while 63% of participants believe that the Department of Veterans Affairs should “allow for research into cannabis as a treatment option.” 

In Other News 

Grow Generation Reports Q3 Earnings Results

Grow Generation is a specialty garden center with 31 locations across 11 US states. The company recently released their third quarter earnings, and reports that, “Revenues rose 153% to $55.0 million, for third quarter 2020, versus $21.8 million for the same period last year.” The company’s gross profit margin for Q3 was 26.5%, compared to 29.9% in the same quarter last year. The company’s online sales increased by 112% year over year. 

Sundial Reports Third Quarter Earnings Results

According to the press release, “Branded net cannabis sales increased to 77% of total cannabis sales from 69% in the previous quarter as Sundial continues to transition from reliance on wholesale to branded retail sales, and “Net cannabis revenue for the third quarter of 2020 was $12.9 million, a decrease of 36% over the second quarter of 2020 due primarily to focus on branded retail sales.”  

“While our third quarter revenue decreased, we are pleased with the demonstrated improvement in operating discipline, successful cost optimization initiatives and a material reduction of our debt,” said Zach George , Sundial’s CEO. “Following the announcement of our financial restructuring in June of this year, we have accelerated improvements in our operating practices targeting a sustainable cost structure and a simplified business model that will better enable us to focus on delighting consumers.”

Kaitlin DomangueKaitlin DomangueNovember 11, 2020


Veterans and Cannabis Use 

The topic of cannabis and veterans comes up quite a bit, for many reasons. Today’s is Veteran’s Day, and on behalf of everyone at Green Market Report, thank you to those of you who served. 

It’s no secret that many veterans are turning to cannabis to combat some of the difficulties they may be facing from serving in the military. There is no one reason a veteran uses cannabis, rather, veterans’ reasons for use go across the board. Missouri even voted to allocate the sales tax on medical marijuana sales to veterans, a trend that is not uncommon throughout other states. 


Post-traumatic stress disorder (PTSD) is one of the most commonly cited reasons among veterans who use cannabis. Post-traumatic stress disorder is when someone, in this case a veteran, experiences heightened anxiety, stress, paranoia, depression, and other symptoms because of the trauma they endured serving. 


This study from researchers at Wayne State University in Detroit, Michigan was published in June of 2020, so the data is very recent. The study suggests that low doses of THC can help regulate trauma-related stress responses and anxiety. The research further concludes that THC in therapeutic doses has the potential to prove advantageous in treating stress and trauma related conditions. It was a randomized, double-blind placebo study – which typically ensures very thorough results. This data is preliminary, but it confirms what veterans have been saying for years about cannabis use and PTSD. In addition to PTSD, veterans may seek the help of cannabis for various other mental health conditions, such as depression or anxiety. Roughly, 11-20 veterans out of every 100 who served in operations Iraqi Freedom and Enduring Freedom have PTSD in a given year. 

Pain is another reason veterans may use cannabis. Many of the men and women who served experience pain from injuries they sustained, as well as just general wear and tear on their body from being in the military. Those who serve stay moving and have a strict exercise regimen, it makes sense that they’d experience pain. 

Veterans Affairs

According to a 2019 survey conducted by Iraq and Afghanistan Veterans of America (IAVA), 75% of military veterans say they’d consider using either “cannabis or cannabinoid products as a treatment option.” 83% of respondents expressed their support for medical cannabis access, while 63% of participants believe that the Department of Veterans Affairs should “allow for research into cannabis as a treatment option.” Unfortunately, cannabis’ federally illegality presents some potential challenges for veterans. Currently, physicians who are affiliated with the Department of Veterans Affairs are not allowed to recommend cannabis for medical use. According to the VA website, veterans who use cannabis will not have their benefits denied. However, like we mentioned above, physicians in the VA system cannot recommend marijuana. The Department of Veterans Affairs still encourages veterans to have conversations with their doctor about marijuana, and make them aware they are participating in the medical marijuana program. 

The Safe Harbor Act 

A bill was introduced in February of 2019 known as the Safe Harbor Act. This bill essentially secures veterans’ right to use, possess, and transport cannabis as needed so long as they are living in a state where it is legal. It also protects their right to discuss marijuana use with their physician. In addition to protecting a veterans’ right to use cannabis, this bill requires the VA to report the effects of medical marijuana on veterans’ pain, as well as the relationship between state-approved medical marijuana treatment programs, program access, and opioid abuse reduction. A portion of the text in the bill reads, “Congress finds the following: 

  • Chronic pain affects the veteran population, with almost 60 percent of veterans returning from serving in the Armed Forces in the Middle East, and more than 50 percent of older veterans, who are using the health care system of the Department of Veterans Affairs living with some form of chronic pain.
  • In 2011, veterans were twice as likely to die from accidental opioid overdoses as nonveterans.” 

Kaitlin DomangueKaitlin DomangueNovember 10, 2020


It’s time for your Daily Hit of cannabis financial news for November 10th, 2020. 

On the Site

Organigram Shares Plunge On New $60 Million Offering

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. announced an underwritten public offering of units of the company led by Canaccord Genuity Corp. who has agreed to purchase 32,500,000 Units from Organigram at a price of C$1.85 per Unit, for total gross proceeds of C$60,125,000.

Indus Holdings Turns Corner Despite Wildfire Challenges

Following the market close on Monday, Indus Holdings, Inc.  (OTCQX: INDXF)reported its financial results for the third quarter ended September 30, 2020, with revenue at $14.1 million. This was a 40% year-over-year growth from the third quarter last year and an increase of 43% from the prior quarter. “Despite the headwinds caused by the wildfires, our Q3 results are the direct result of a strategy that prioritizes increased cultivation output and the Indus family of owned products,” says Mark Ainsworth, Chief Executive Officer for Indus Holdings, Inc.

Zappy Wants You To Join The Mind Army

Mike “Zappy” Zapolin participates in both sides of the psychedelic marketplace. He’s an advocate for the use of psychedelic drugs and fights for legalization with his group, the Mind Army. He’s also a businessman and is building a ketamine company because of his passion for treating people. Green Market Report was able to chat with Zappy on several psychedelic topics, watch the video on YouTube here

In Other News

Harvest Health Reports Third Quarter Results for 2020 

Harvest Health reported a revenue of $61.6 million for Q3, which is up a whopping 86% from 2019’s third quarter. The adjusted EBITDA for Q3 2020 was $10.5 million, a big jump compared to $4.1 million in the second quarter of 2020. 

Kaitlin DomangueKaitlin DomangueNovember 9, 2020


Canadian-based cannabis company, Aurora Cannabis (NYSE: ACB) reported their Q1 earnings this morning. The results were mixed at best, with shares rising 21% on the potential for cannabis legalization under a Biden administration. Unless otherwise stated, these figures are in Canadian dollars. 

The company’s adjusted gross margin before fair value adjustments on total cannabis net revenue didn’t waver much quarter to quarter, with Aurora Cannabis reporting a 48% adjusted gross margin compared to 50% in Q4 2020. Before fair value adjustments, the company’s adjusted gross margin on cannabis net revenue was 52%. 

Consumer Cannabis 

Aurora reported a slight increase in total and net revenue in Q1, with numbers reaching $67.8 million. Q4’s revenue totaled $67.5 million, so while the increase was small, it was there. 

Consumer cannabis net revenue, however, was down 3% quarter over quarter, reaching a stop at $34.3 million. The adjusted gross margin before fair value adjustments on consumer cannabis net revenue was 38% compared to 35% in the prior quarter. Aurora cites sales mix shifting towards higher margin derivative products as the reason for this increase. 

One area where Aurora really shined in Q1 is in consumer cannabis extracts, with the net revenue increasing by $3.6 million sequentially. Aurora says this was driven by their focus on high-growth extracts such as vapes, edibles, and concentrates, plus a $1.1 million increase in US CBD. 

Medical Cannabis

The company reported a 4% sequential increase in medical cannabis net revenue, ultimately capping out at $33.5 million. Aurora primarily attributes this growth to their strong international medical cannabis presence, which grew a whopping 41% quarter over quarter. 

“Our Q1 2021 results are transitional but do highlight successes across a number of diverse profit pools,” said Miguel Martin, CEO of Aurora. “We remain the leader by revenue in the high-margin Canadian medical market, our international medical business experienced more than 40% net revenue growth this quarter, and our CBD brand Reliva is #1 ranked by Nielsen in the U.S. CBD sector.”

The adjusted gross margin on medical cannabis before fair value adjustments was 59% versus 67% in the prior quarter. This is excluding $2.6 million in ramp up costs at Aurora Nordic 1, which is a large cannabis facility located in Denmark. 


Aurora’s adjusted EBITDA loss was $57.9 million in Q1, with the company including restructuring payments such as contract and employee termination costs of $47.4 million. Excluding these impacts, the adjusted EBITDA loss as defined under the term credit facility is $10.5 million. Aurora says they remain on track to achieve a positive adjusted EBITDA next quarter. 

Cash Use

Aurora Cannabis used $25.2 million cash in Q1 to fund company operations, and used $47.4 million for contract and employee termination costs. This is similar to the prior quarter, however, the use of cash showed significant progress. Cash used to pay for capital expenditures in the first quarter was $15 million compared to $32 million in the prior quarter, as many of their projects are now wrapping up and completing. 

Increased net working capital used $37.0 million in the quarter, driven by a $13.8 million increase in accounts receivable and a $25.1 million increase in inventory.

“While we are not satisfied with our past performance in the growing Canadian consumer business, we have a sense of urgency in the execution of our tactical plan to grow profitable market share. Our efforts are directed at delivering the highest quality products, refocusing on our leading premium and ultra-premium brands, better allocating our sales and marketing spend, and executing key account partnerships at both the province and retail levels.”

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 6 days

The Daily Hit: November 25, 2020

@GreenMarketRpt – 6 days

$PLNHF ⁦@Planet13lv⁩ Revenue Rises 36% To $22 Million, Turns A Profit

@GreenMarketRpt – 6 days

$VREOF ⁦@VireoHealth⁩ Revenue Rises 67%, Turns Profitable

Back to Top

You have Successfully Subscribed!